Pomalidomide-Dexamethasone Effectiveness in t(11;14) Positive Relapsed Multiple Myeloma in Real-World Setting
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Sudeep Karve, Shaji Kumar, Veronica Gonzalez De La Calle, Silvia Mangiacavalli, Chang-Ki Min, Efstathios Kastritis, Graca Esteves, Michel Delforge, Fernando Escalante, Jin Lu, Yang Liu, Max Bittrich, Charalampia Kyriakou, Andrew J. Yee, Emma Arriola, Jeremy A. Ross, Shivaji Manthena, Brian G.M. Durie
Institutions: AbbVie (United States), Mayo Clinic, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, Policlinico San Matteo Fondazione, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, National and Kapodistrian University of Athens, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Universitair Ziekenhuis Leuven, Hospital Universitario de León, Peking University People's Hospital, Universitätsklinikum Würzburg, University College Hospital, University College London Hospitals NHS Foundation Trust, University College London, Massachusetts General Hospital, AbbVie (United Kingdom), Cedars-Sinai Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3214443089
